• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 40025
Device Problems Incomplete Coaptation (2507); Patient Device Interaction Problem (4001); Central Regurgitation (4068)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 03/12/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that during the implant of this 25mm aortic bioprosthetic valve, it was explanted and replaced with a bioprosthetic valve of an different manufacturer.The reason for the replacement was reported as "bad leaflet coaptation, huge regurgitation." it was noted that the valve was not inspected prior to implant it, the incomplete coaptation was noticed after implantation, the sizers used were for the product and both the barrel end and replica end were used, a body surface area (bsa) chart was not used for valve sizing, the annulus was not felt to be between sizes, a root enlargement was not performed, pledgets were used, the valve was not re-sized following the pledget placement, it was the surgeons 3rd implantation with this product, and no clinical field support were present.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVALUS AORTIC TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18943529
MDR Text Key338153900
Report Number2025587-2024-01788
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeBU
PMA/PMN Number
P170006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number40025
Device Catalogue Number40025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/12/2024
Initial Date FDA Received03/20/2024
Date Device Manufactured01/29/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age48 YR
Patient SexMale
Patient Weight93 KG
-
-